Cytek biosciences earnings call
WebMar 31, 2024 · Cytek Biosciences now expects full year 2024 revenue to be closer to the high end of the range of $160 million to $168 million. Webcast Information Cytek will host a conference call to discuss the first quarter 2024 financial results on Wednesday, May 11, 2024, at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time. WebFeb 28, 2024 · Other than Cytek’s Northern Lights CLC system, which is available for clinical use in China and the European Union, Cytek’s products are for research use only – not for use in diagnostic procedures. Stock Information $8.75 NASDAQ GS: CTKB 0 … The Investor Relations website contains information about Cytek Biosciences's … Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from … Mar 24, 2024: 144: Filed by "insiders" prior intended sale of restricted stock. Non … Cytek Biosciences Fourth Quarter and Full Year 2024 Earnings Conference Call. … Cytek Biosciences, CEO. Wenbin Jiang, Ph.D. has served as Cytek’s Chief … The Investor Relations website contains information about Cytek Biosciences's … Cytek was incorporated in Delaware in 2014 under the name Cytoville, Inc. In August …
Cytek biosciences earnings call
Did you know?
WebMar 1, 2024 · Cytek Biosciences, Inc. (NASDAQ:NASDAQ:CTKB) Q4 and Full Year 2024 Earnings Conference Call February 28, 2024 4:30 PM ETCompany ParticipantsPaul … WebFeb 6, 2024 · Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 28, 2024. Feb 07, 2024.
WebAug 10, 2024 · Q2 2024 Cytek Biosciences Inc Earnings Call Sep 21, 2024 (Thomson StreetEvents) -- Edited Transcript of Cytek Biosciences Inc earnings conference call … WebCytek Biosciences Fourth Quarter and Full Year 2024 Earnings Conference Call Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results Form 10-K …
WebMar 1, 2024 · Cytek Biosciences, Inc. (CTKB) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to … WebFeb 28, 2024 · Provides full year 2024 revenue guidance of $225 million to $235 million, or growth of 37% to 43% over full year 2024. FREMONT, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) — Cytek ® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) ( Nasdaq: CTKB) today reported financial results for the fourth quarter and year ended December …
WebMar 1, 2024 · Welcome to the Cytek Fourth Quarter and Full Year 2024 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is …
WebApr 13, 2024 · RBC Capital Markets is positief over het aandeel met een koopadvies. Voorheen was het koersdoel 579 USD, maar deze is licht aangepast naar 582 USD. 13 april 2024 immunoablative therapyWebFeb 28, 2024 · Cytek Biosciences, Inc., which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $48.34 million for the quarter ended December 2024, missing the Zacks... immunoadsorption 英语翻译Web2 days ago · Cytek Biosciences, Inc.: Jiang Wenbin (Director, President and CEO) Sells 20,000 @ Avg Price: $8.88 (Form4) Accepted: April 11, 2024 at 10:04 PM UTC Form Type: 4 list of wall street firmsWeb哪里可以找行业研究报告？三个皮匠报告网的最新栏目每日会更新大量报告，包括行业研究报告、市场调研报告、行业分析报告、外文报告、会议报告、招股书、白皮书、世界500强企业分析报告以及券商报告等内容的更新，通过最新栏目，大家可以快速找到自己想要的内容。 immunoactive prophylaxisWebNov 9, 2024 · Sector news Transcript : Cytek Biosciences, Inc., Q3 2024 Earnings Call, Nov 09, 2024 11/09/2024 04:30pm EDT Welcome to Cytek's Third Quarter 2024 … list of walking dead episoded juneWebNov 9, 2024 · Cytek Biosciences, Inc. , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $40.48 million for the quarter ended September 2024, missing the Zacks... immunoaffinity中文WebFeb 24, 2024 · Cytek Biosciences, Inc. (NASDAQ:NASDAQ:CTKB) Q4 2024 Earnings Conference Call February 23, 2024 5:00 PM ETCompany ParticipantsAlex Khan - … immunmediierte thrombozytopenie hund